跳至主要内容
临床试验/NL-OMON45369
NL-OMON45369已完成不适用

First-In Man (FIM) study MR-Linac - FIM MR-Linac

Elekta0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Elekta
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • * Painful bone metastases in the lumbar spine
  • * Radiographic evidence of bone metastases
  • * Histologic proof of malignancy
  • * Karnofsky Performance Score * 50
  • * Age * 18 years
  • * Able to provide a written informed consent

排除标准

  • * Prior radiation therapy within the region planned to be irradiated
  • * Contraindication for MRI according to screening protocol radiology department UMCU (e.g. cardiac pacemakers, and defibrillators, artificial heart valves or cochlear implants, https://richtlijn.mijnumc.nl/Beeld/MRI/Paginas/MRI-Veiligheid-Contra-indicaties.aspx
  • * Claustrophobia
  • * Standard chemotherapy or radionuclide therapy within 48 hours before or after treatment
  • * Any other type of systemic anti-cancer treatment, except for endocrine treatment
  • * Unstable spine requiring surgical stabilization
  • * Neurological deficit
  • * Not able to provide a written informed consent

研究者

发起方
Elekta

相似试验